Jump Financial’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
Jump Financial's CORT Position: Q2 2026 in Review
Jump Financial sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 46,848 shares — an estimated $1.89M sold.
Jump Financial first reported a position in CORT in Q4 2020 and held it in 14 quarters. The position peaked at $2.21M in Q2 2022. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Jump Financial reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
- Jump Financial sold 46,848 Corcept Therapeutics shares in Q2 2026, an estimated $1.89M.
- Jump Financial first reported a position in Corcept Therapeutics in Q4 2020 and held it in 14 quarters.
- Jump Financial's Corcept Therapeutics position peaked at $2.21M in Q2 2022.
- 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.